DOI QR코드

DOI QR Code

Clinical Features of Severely Constipated Children: Comparison of Infrequent Bowel Movement and Fecal Soiling Groups

  • Lee, Gyung (Department of Pediatrics, Konkuk University School of Medicine) ;
  • Son, Jae Sung (Department of Pediatrics, Konkuk University School of Medicine) ;
  • Bae, Sun Hwan (Department of Pediatrics, Konkuk University School of Medicine)
  • Received : 2019.06.13
  • Accepted : 2019.08.23
  • Published : 2020.01.15

Abstract

Purpose: To compare the clinical features, diagnostic findings, and medications of children with infrequent bowel movements or fecal soiling. Methods: This study enrolled 333 children (189 male; age range, 1 month to 18 years) diagnosed with functional constipation by Rome III or IV criteria. We classified them into 3 groups (infrequent bowel movement without fecal soiling [G3-a], infrequent bowel movement with fecal soiling [G3-b], and fecal soiling only [G3-c]) and into 2 subgroups of fecal soiling (G2-b) or not (G2-a). Retrospective data on clinical characteristics, colon transit time (CTT) test results, and medications were collected. The Wilcoxon rank-sum test, Kruskal-Wallis test, Chi-square test, and Fisher's exact test were used for the statistical analysis. Results: The median age (months) and interquartile range (IQR) was 33 (45) in G3-a, 54 (40) in G3-b, and 73 (48) in G3-c (p<0.0001). G3-c had the latest onset (median, 18; IQR, 18; p=0.0219) and longest symptom duration (24 [24], p=0.0148). PEG 4000 was used in 60.6% (G3-a), 96.8% (G3-b), and 83.2% (G3-c) of patients (p<0.0001). The median age (months) and IQR were 33.0 (45.0) in G2-a and 63.5 (52.5) in G2-b (p<0.0001). G2-b had later onset (median, 12; IQR, 19.5; p=0.0062) and longer symptom duration than G2-a (24 [12], p=0.0070). PEG 4000 was used in 60.6% (G2-a) and 88.3% (G2-b) of children (p<0.0001). No statistically significant intergroup differences were seen in maintenance laxative dose, CTT, or CTT type. Conclusion: Infrequent bowel movement and fecal soiling represent the advanced stage of chronic functional constipation.

Keywords

References

  1. Youssef NN, Di Lorenzo C. Childhood constipation: evaluation and treatment. J Clin Gastroenterol 2001;33:199-205. https://doi.org/10.1097/00004836-200109000-00006
  2. Southwell BR, King SK, Hutson JM. Chronic constipation in children: organic disorders are a major cause. J Paediatr Child Health 2005;41:1-15. https://doi.org/10.1111/j.1440-1754.2005.00527.x
  3. Poenaru D, Roblin N, Bird M, Duce S, Groll A, Pietak D, et al. The pediatric Bowel Management Clinic: initial results of a multidisciplinary approach to functional constipation in children. J Pediatr Surg 1997;32:843-8. https://doi.org/10.1016/S0022-3468(97)90633-3
  4. Chanpong A, Osatakul S. Laxative choice and treatment outcomes in childhood constipation: clinical data in a longitudinal retrospective study. Pediatr Gastroenterol Hepatol Nutr 2018;21:101-10. https://doi.org/10.5223/pghn.2018.21.2.101
  5. Bae SH, Kim MR. Subtype classification of chronic functional childhood constipation with a colon transit time test: therapeutic perspective. Paper presented at: 5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition; 2016 Oct 5-8; Montreal, Canada. p. 252.
  6. Treepongkaruna S, Simakachorn N, Pienvichit P, Varavithya W, Tongpenyai Y, Garnier P, et al. A randomised, double-blind study of polyethylene glycol 4000 and lactulose in the treatment of constipation in children. BMC Pediatr 2014;14:153. https://doi.org/10.1186/1471-2431-14-153
  7. Kim MR, Park HW, Son JS, Lee R, Bae SH. Correlation between colon transit time test value and initial maintenance dose of laxative in children with chronic functional constipation. Pediatr Gastroenterol Hepatol Nutr 2016;19:186-92. https://doi.org/10.5223/pghn.2016.19.3.186
  8. Metcalf AM, Phillips SF, Zinsmeister AR, MacCarty RL, Beart RW, Wolff BG. Simplified assessment of segmental colonic transit. Gastroenterology 1987;92:40-7. https://doi.org/10.1016/0016-5085(87)90837-7
  9. Clayden GS, Keshtgar AS, Carcani-Rathwell I, Abhyankar A. The management of chronic constipation and related faecal incontinence in childhood. Arch Dis Child Educ Pract 2005;90:ep58-67. https://doi.org/10.1136/adc.2004.066019
  10. Biggs WS, Dery WH. Evaluation and treatment of constipation in infants and children. Am Fam Physician 2006;73:469-77.
  11. Felt B, Wise CG, Olson A, Kochhar P, Marcus S, Coran A. Guideline for the management of pediatric idiopathic constipation and soiling. Multidisciplinary team from the University of Michigan Medical Center in Ann Arbor. Arch Pediatr Adolesc Med 1999;153:380-5. https://doi.org/10.1001/archpedi.153.4.380
  12. Voderholzer WA, Schatke W, Muhldorfer BE, Klauser AG, Birkner B, Muller-Lissner SA. Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol 1997;92:95-8.
  13. Rao SS. Constipation: evaluation and treatment of colonic and anorectal motility disorders. Gastroenterol Clin North Am 2007;36:687-711. https://doi.org/10.1016/j.gtc.2007.07.013
  14. Knowles CH, Scott SM, Wellmer A, Misra VP, Pilot MA, Williams NS, et al. Sensory and autonomic neuropathy in patients with idiopathic slow-transit constipation. Br J Surg 1999;86:54-60. https://doi.org/10.1046/j.1365-2168.1999.00994.x
  15. Knowles CH, Martin JE. Slow transit constipation: a model of human gut dysmotility. Review of possible aetiologies. Neurogastroenterol Motil 2000;12:181-96. https://doi.org/10.1046/j.1365-2982.2000.00198.x
  16. Tzavella K, Riepl RL, Klauser AG, Voderholzer WA, Schindlbeck NE, Muller-Lissner SA. Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroenterol Hepatol 1996;8:1207-11. https://doi.org/10.1097/00042737-199612000-00014
  17. Cortesini C, Cianchi F, Infantino A, Lise M. Nitric oxide synthase and VIP distribution in enteric nervous system in idiopathic chronic constipation. Dig Dis Sci 1995;40:2450-5. https://doi.org/10.1007/BF02063253
  18. Rao SSC, Parkman HP, McCallum RW. Handbook of gastrointestinal motility and functional disorders. Thorofare: SLACK Incorporated, 2015.
  19. Saad MRJ. Slow transit constipation. In: Rao SSC, Parkman HP, McCallum RW, eds. Handbook of gastrointestinal motility and functional disorders. Thorofare: SLACK Incorporated, 2015:241-52.
  20. Attaluri A, Jackson M, Valestin J, Rao SS. Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol 2010;105:1407-11. https://doi.org/10.1038/ajg.2009.655
  21. Kim K, Jeon HJ, Bae SH. Value of fluoroscopic defecography in constipated children with abnormal colon transit time test results. J Neurogastroenterol Motil 2019. doi: 10.5056/jnm18201. [Epub ahead of print].
  22. Lee G, Jeon HJ, Bae SH. Pelvic floor dysfunction in chronic constipated children. Paper presented at: The 68th Fall Conference, The Korean Pediatric Society; 2018 Oct 18; Seoul, Korea.
  23. Nelson RL. Epidemiology of fecal incontinence. Gastroenterology 2004;126(1 Suppl 1):S3-7. https://doi.org/10.1053/j.gastro.2003.10.010
  24. Lembo AJ. Constipation. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's gastrointestinal and liver disease. 10th ed. Amsterdam: Elsevier Inc., 2016:270-96.
  25. Rajindrajith S, Devanarayana NM, Benninga MA. Review article: faecal incontinence in children: epidemiology, pathophysiology, clinical evaluation and management. Aliment Pharmacol Ther 2013;37:37-48. https://doi.org/10.1111/apt.12103
  26. Griffiths DM. The physiology of continence: idiopathic fecal constipation and soiling. Semin Pediatr Surg 2002;11:67-74. https://doi.org/10.1053/spsu.2002.31804
  27. Whitehead WE, Chiarioni G. Fecal incontinence. In: Rao SSC, Parkman HP, McCallum RW, eds. Handbook of gastrointestinal motility and functional disorders. Thorofare: SLACK Incorporated, 2015:265-78.
  28. Kliegman RM, St Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM. Nelson textbook of pediatrics. 21th ed. Philadelphia: Elsevier, 2019. 2045 p.
  29. Yoo HY, Kim MR, Park HW, Son JS, Bae SH. Colon transit time test in Korean children with chronic functional constipation. Pediatr Gastroenterol Hepatol Nutr 2016;19:38-43. https://doi.org/10.5223/pghn.2016.19.1.38
  30. Benninga MA, Buller HA, Tytgat GN, Akkermans LM, Bossuyt PM, Taminiau JA. Colonic transit time in constipated children: does pediatric slow-transit constipation exist? J Pediatr Gastroenterol Nutr 1996;23:241-51. https://doi.org/10.1097/00005176-199610000-00007
  31. Wagener S, Shankar KR, Turnock RR, Lamont GL, Baillie CT. Colonic transit time--what is normal? J Pediatr Surg 2004;39:166-9; discussion 166-9. https://doi.org/10.1016/j.jpedsurg.2003.10.002
  32. Lee-Robichaud H, Thomas K, Morgan J, Nelson RL. Lactulose versus Polyethylene Glycol for chronic constipation. Cochrane Database Syst Rev 2010;(7):CD007570.
  33. Dupont C, Leluyer B, Maamri N, Morali A, Joye JP, Fiorini JM, et al. Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. J Pediatr Gastroenterol Nutr 2005;41:625-33. https://doi.org/10.1097/01.mpg.0000181188.01887.78
  34. Voskuijl W, de Lorijn F, Verwijs W, Hogeman P, Heijmans J, Makel W, et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut 2004;53:1590-4. https://doi.org/10.1136/gut.2004.043620
  35. Lee SH, Bae SH. Maintenance dose of electrolyte free polyethylene glycol (PEG) 4000 in Korean children with chronic functional constipation. Korean J Pediatr 2007;50:1212-6. https://doi.org/10.3345/kjp.2007.50.12.1212

Cited by

  1. Subtype classification of functional constipation in children: polyethylene glycol versus lactulose vol.62, pp.7, 2020, https://doi.org/10.1111/ped.14235
  2. Prevalence of Defecation Disorders and their Symptoms is Comparable in Children and Young Adults: Cross-Sectional Study vol.24, pp.1, 2020, https://doi.org/10.5223/pghn.2021.24.1.45